A controlled trial of imipramine for the treatment of methamphetamine dependence.
about
Treatment for amphetamine dependence and abusePharmacotherapy of methamphetamine addiction: an updatePharmacotherapy of amphetamine-type stimulant dependence: an updateA systematic review of behavioral and treatment outcome studies among HIV-infected men who have sex with men who abuse crystal methamphetamineEffect of add-on valproate on craving in methamphetamine depended patients: A randomized trialPharmacological treatments for methamphetamine addiction: current status and future directions.Treatment for amphetamine dependence and abuse.Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.A review of treatment options for co-occurring methamphetamine use disorders and depressionSustained reductions in drug use and depression symptoms from treatment for drug abuse in methamphetamine-dependent gay and bisexual men.Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot StudyPredictors of safer sex intentions and protected sex among heterosexual HIV-negative methamphetamine users: an expanded model of the Theory of Planned Behavior.Patterns of methamphetamine use and symptoms of depression among young adults in northern Thailand.Amphetamines, the pregnant woman and her children: a review.Utility of preclinical drug versus food choice procedures to evaluate candidate medications for methamphetamine use disorder.Methamphetamine-Related Disorders.Correlates of outpatient drug treatment drop-out among methamphetamine users.A descriptive analysis of participant characteristics and patterns of substance use in the CSAT methamphetamine treatment project: the first six months.Predictors of relapse after treatment for methamphetamine use.An open-label pilot study of risperidone in the treatment of methamphetamine dependence.Status of methamphetamine users 2-5 years after outpatient treatment.An exploratory study: the use of paroxetine for methamphetamine craving.Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving.
P2860
Q24197542-2980E4F3-CD80-4666-917C-50FCFCF3B847Q24648913-D2BBC132-48A4-4687-A70E-D80338EC0DBAQ26991936-470CBAA0-B7EC-42A2-9378-0ACFF9E57BF6Q27027539-09850B06-3071-40B6-8873-5B73C1A55E89Q28595633-1171D56B-D1F5-4494-A8F4-309BBAD89C6EQ30240173-5801F508-3314-44C2-B3B7-9B7F9FDB69B9Q32026722-14358008-9147-45C7-9C57-A26363AF2D5BQ33873511-7D74D86D-060A-4F65-BFED-E2C29F7B9D78Q33904064-5B4AEF91-017E-4E7A-A683-6612EBE41B23Q36273152-BEA98B73-96F1-4ECC-A0FE-23F37E01F33BQ36387048-5FDB1C5A-E9E8-40F8-A423-C6C3DF12D990Q37074043-2CBC98C3-33DD-4A13-A1D6-4880DCA4A2A2Q37218242-D8F9B19F-8D2D-4FB7-8521-E814CD0A8397Q38015058-EFB63576-F62E-477D-8A9F-44DB566FFB7BQ39034288-904CF93A-9DFC-480F-A696-435976A94FACQ39433370-F4D4CEBF-0BF3-4F92-ACB5-F70973A25714Q40756012-AFCB85FE-57B9-4833-A00A-AF1A8F8C6C9EQ41749640-4A69DBD7-BA92-4DCF-8F8A-241CA35B709DQ41749656-3AFA8576-8171-447C-AF9C-F362447061AEQ42629242-F1082509-6E62-4E81-9ECD-306758AF0449Q43878790-7327C017-B365-4699-AE4C-D082F4E945E7Q44209897-C8A8F474-C9E2-4D9A-81F5-8D6BEAFF40F4Q46337700-B4631998-FB00-4086-B0BA-06497129AE17
P2860
A controlled trial of imipramine for the treatment of methamphetamine dependence.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
A controlled trial of imipramine for the treatment of methamphetamine dependence.
@en
A controlled trial of imipramine for the treatment of methamphetamine dependence.
@nl
type
label
A controlled trial of imipramine for the treatment of methamphetamine dependence.
@en
A controlled trial of imipramine for the treatment of methamphetamine dependence.
@nl
prefLabel
A controlled trial of imipramine for the treatment of methamphetamine dependence.
@en
A controlled trial of imipramine for the treatment of methamphetamine dependence.
@nl
P2093
P1476
A controlled trial of imipramine for the treatment of methamphetamine dependence.
@en
P2093
P304
P356
10.1016/S0740-5472(96)00154-7
P577
1996-11-01T00:00:00Z